<p>On day 28 after allogeneic BMT, macroscopic findings of the skin indicated erythematous rush and alopecia (A, B). Light microscopic findings showed inflammatory cells, mainly CD3+ T-cells, infiltrating the epidermis and the hair follicle in the dermis, indicating acute GVHD in the skin (C, D: HE stain, E: CD3 stain, C: ×400, D, E: ×800). Inflammatory cells, mainly CD3+ T-cells, infiltrated the portal areas and spread to the hepatic lobules with cholangiolitis and phlebitis in the portal and central veins, indicating acute GVHD in the liver (F, G: HE stain, H: CD3 stain, F: ×400, G, H: ×800). In the colon, erosion and inflammatory cell infiltration was noted with cryptitis and infiltration of CD3+ T-cells, indicating acute GVHD in the col...
Graft-versus-host disease (GVHD) after liver transplantation, although rare, is well documented in l...
The pathogenesis of acute graft versus host disease (GVHD) is multistep process. This review conside...
AbstractDespite impressive advances in the field of allogeneic hematopoietic transplantation, graft ...
Graft-versus-host disease (GvHD) is the major cause of morbidity and mortality following bone marrow...
Engraftment by donor lymphocytes in an immunologically compromised host can result in donor T-cell a...
Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI)...
Graft versus host disease (GVHD) is the main complication of allogeneic hematopoietic cell transplan...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Graft-versus-host disease (GVHD) remains a major complication of bone marrow transplantation. This r...
Aim: Acute graft-versus-host disease (GVHD) is an complication after allogeneic hematopoietic stem c...
The graft-versus-host disease (GvHD) is frequent complication, it occurs in 50% of patients after al...
The use of allogeneic hematopoietic cell transplantation (HCT) has increased as new techniques have ...
Follicular graft-vs-host disease (GVHD) was probably first reported in 1984.1 Clinically acute folli...
Herein, we describe an unusual presentation of acute graft versus host disease (GVHD) mimicking cont...
<p>Liver and intestines (small and large) tissue sections were harvested from the same mice as descr...
Graft-versus-host disease (GVHD) after liver transplantation, although rare, is well documented in l...
The pathogenesis of acute graft versus host disease (GVHD) is multistep process. This review conside...
AbstractDespite impressive advances in the field of allogeneic hematopoietic transplantation, graft ...
Graft-versus-host disease (GvHD) is the major cause of morbidity and mortality following bone marrow...
Engraftment by donor lymphocytes in an immunologically compromised host can result in donor T-cell a...
Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI)...
Graft versus host disease (GVHD) is the main complication of allogeneic hematopoietic cell transplan...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Graft-versus-host disease (GVHD) remains a major complication of bone marrow transplantation. This r...
Aim: Acute graft-versus-host disease (GVHD) is an complication after allogeneic hematopoietic stem c...
The graft-versus-host disease (GvHD) is frequent complication, it occurs in 50% of patients after al...
The use of allogeneic hematopoietic cell transplantation (HCT) has increased as new techniques have ...
Follicular graft-vs-host disease (GVHD) was probably first reported in 1984.1 Clinically acute folli...
Herein, we describe an unusual presentation of acute graft versus host disease (GVHD) mimicking cont...
<p>Liver and intestines (small and large) tissue sections were harvested from the same mice as descr...
Graft-versus-host disease (GVHD) after liver transplantation, although rare, is well documented in l...
The pathogenesis of acute graft versus host disease (GVHD) is multistep process. This review conside...
AbstractDespite impressive advances in the field of allogeneic hematopoietic transplantation, graft ...